ValorQ4, 24Q1, 25Q2, 25Q3, 25Q4, 25TTMGastos comerciales, generales y administrativos625 M563 M617 M579 M619 M2.38 BInvestigación y desarrollo186 M157 M172 M170 M199 M698 MBeneficio operativo548 M899 M921 M890 M643 M3.35 BTotal de ingresos no operativos20 M18 M-4 M13 M9 M36 MGastos por intereses, netos de intereses capitalizados51 M54 M53 M58 M57 M222 MIngresos no operativos, una vez deducidos los gastos por intereses-32 M-39 M-56 M-45 M-40 M-180 MIngresos/gastos extraordinarios1 M3 M-1 M0-8 M-6 MBeneficio antes de impuestos732 M810 M902 M887 M761 M3.36 BParticipación en los beneficios——————Impuestos151 M179 M184 M166 M158 M687 MParticipación minoritaria000000Otros ingresos/gastos después de impuestos17 M2 M3 M4 M-1 M8 MBeneficio neto antes de actividades interrumpidas581 M631 M718 M721 M603 M2.67 BOperaciones suspendidas——————Beneficio neto581 M631 M718 M721 M603 M2.67 BAjuste por dilución——————Dividendos de las acciones preferentes——————Beneficio neto diluido atribuible a los accionistas581 M631 M718 M721 M603 M2.67 BBeneficio básico por acción1.281.411.611.631.386.03Beneficio por acción diluido1.291.411.611.631.376.02Número medio de acciones ordinarias454.2 M447.6 M445.1 M442.9 M443.44 M1.78 BAcciones diluidas454.85 M448 M445.5 M443.2 M443.83 M1.78 BEBITDA671 M1.02 B1.04 B1.01 B764 M3.84 BEBIT548 M899 M921 M890 M643 M3.35 BCosto de los ingresos707 M622 M649 M683 M712 M2.67 BOtros costes de producción26 M18 M14 M20 M16 M68 MAmortización y depreciación (flujo de caja)123 M119 M123 M124 M121 M487 M
Zoetis Inc Class A
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index.